Clinical Trial Update March 2026 - Takeaways - MDSpire

Clinical Trial Update March 2026

  • March 1, 2026

  • 40 min

Share

  • 1

    The article provides updates on various clinical trials for age-related macular degeneration (AMD) and related conditions.

  • 2

    A Phase 1 study of ABF-101 aims to evaluate its safety and tolerability in participants with AMD.

  • 3

    CTx001 is being tested in a Phase 1/2 trial for safety and efficacy in geographic atrophy secondary to AMD.

  • 4

    Multiple studies are assessing the safety and efficacy of intravitreal injections for geographic atrophy associated with AMD.

  • 5

    SGLT2 inhibitors are under investigation for their potential effects on geographic atrophy related to AMD.

Original Source(s)

Related Content